Cy5 labeled plasmids - cGas agonist

Fluorescently labeled plasmids - Null or GFP - for gene tracking studies

SPECIFICATIONS

Specifications

Source
Synthetic
Target

cGAS

Working concentration

1 ng/ml - 1 μg/ml

Solubility

100 mg/ml in water

Appearance (form)
Dried
Reconstitution buffer
Endotoxin-free water (provided)
Endotoxin

The absence of bacterial contamination (e.g. lipoproteins and endotoxins) has been confirmed using HEK-Blue™ TLR2 and HEK‑Blue™ TLR4 cells.

Applications

Flow cytometry

Fluorescent microscopy

Confocal microscopy

PRR activation studies

In vitro and in vivo tracking for gene delivery studies

Quality control

Each lot is functionally tested and validated.

Additional information

Spectral Properties

  • Excitation λ max: 647 nm (Cy5)
  • Emission λ max: 665 nm (Cy5)

CONTENTS

Contents

  • Product: 
    pUNO2-Null-Cy5
  • Cat code: 
    puno2-nullcy5
  • Quantity: 
    10 µg
Includes:

1.5 ml sterile endotoxin-free water

Shipping & Storage

  • Shipping method:  Room temperature
  • Storage:

    • -20°C
    Stability: -20°C for up to 1 year

    Caution:

    • Avoid repeated freeze-thaw cycles
    • Protect from light

Details

Cyclic GMP-AMP synthase, also known as cGAS or cGAMP synthase, is the primary sensor of cytosolic double-stranded DNA (dsDNA), a danger signal indicating possible disturbances in homeostasis caused by infection, sterile tissue damage, or cancer [1]. It triggers innate immune responses through the production of type I interferons (IFNs) [2]. 

In response to cytosolic dsDNA (e.g., microbial DNA, mitochondrial DNA, extracellular self-DNA), cGAS catalyzes its substrates GTP and ATP (guanosine triphosphate and adenosine triphosphate [ATP]) into the cyclic dinucleotide (CDN) 2’3’-cGAMP. CDNs bind directly to the stimulator of interferon genes (STING), leading to TBK1‑IRF3-mediated activation of IFN-stimulated response elements (ISRE) in the promoters of IFN-stimulated genes (ISG) [1,3,4].

Current research on the cGAS–STING pathway is focusing on finding new cancer therapies, considering its role in inducing cell-intrinsic processes, such as autophagy, cellular senescence, and cell death. In contrast, dysregulated or excessive activation of the cGAS–STING pathway can cause primary pathogenesis and the manifestation of several autoimmune diseases; thus, identifying compounds, delivery pathways, and treatment regimens targeting the suppression of the cGAS–STING pathway can provide novel approaches to alleviate the symptoms of autoimmune disorders or inflammation [1].

 

References:

1. Zhou J, et al., 2023. Significance of the cGAS-STING Pathway in Health and Disease. Int J Mol Sci. 24(17):13316.
2. Sun L. et al., 2013. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339(6121):786-91.
3. Gao P. et al., 2013. Cyclic [G(2’,5’)pA(3’,5’)p] is the metazoan second messenger produced by DNA-activated cyclic GMP-AMP synthase. Cell. 153(5):1094-107.
4. Ablasser A. et al., 2013. cGAS produces a 2’-5’-linked cyclic dinucleotide second messenger that activates STING. Nature. 498(7454):380-4.
5. Lama L, et al. 2019. Development of human cGAS-specific small-molecule inhibitors for repression of dsDNA-triggered interferon expression. Nat Commun.10(1):2261.

DOCUMENTS

Documents

pUNO2-Null-Cy5

Technical Data Sheet

Validation Data Sheet

Safety Data Sheet

Certificate of analysis

Need a CoA ?

CUSTOMER SERVICE & TECHNICAL SUPPORT

Question about this product ?